Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Action limits in hyperlipidemia.

O Faergeman1

  • 1Department of Internal Medicine and Cardiology, Aarhus Amtssygehus University Hospital DK.

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Upper-limb thrombo-embolectomy: national cohort study in Denmark.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2010
Same author

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Journal of internal medicine·2010
Same author

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.

Lancet (London, England)·2008
Same author

[Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect].

Genetika·2007
Same author

Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons.

Journal of epidemiology and community health·2006
Same journal

Standardization of tumor markers - priorities identified through external quality assessment.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

microRNAs as cancer biomarkers.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Biomarkers along the continuum of care in lung cancer.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Precision medicine: what's all the fuss about?

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Serum thyroglobulin in the monitoring of differentiated thyroid cancer.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
See all related articles

International guidelines for hyperlipidemia management, like those from the European Atherosclerosis Society and National Cholesterol Education Program, use low cholesterol action limits. Differences in these limits can impact large population segments.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Lipidology

Background:

  • Hyperlipidemia diagnosis and treatment guidelines are established by international and national bodies.
  • Prominent guidelines include those from the European Atherosclerosis Society and the US National Cholesterol Education Program.
  • These guidelines aim to manage cardiovascular disease risk associated with elevated cholesterol levels.

Purpose of the Study:

  • To analyze and compare international and national guidelines for hyperlipidemia management.
  • To examine the basis for differing action limits in hyperlipidemia treatment.
  • To assess the population impact of variations in cholesterol action limits.

Main Methods:

  • Review of published guidelines from major international and national health organizations.

Related Experiment Videos

  • Analysis of the epidemiological and interventional data underpinning proposed action limits.
  • Comparison of proposed action limits for serum cholesterol concentrations.

    • Main Results:

    • Guidelines from the European Atherosclerosis Society and National Cholesterol Education Program recommend low action limits (4-5 mmol/L) based on observational data.
    • Some countries propose higher, more conservative action limits derived from intervention studies.
    • Even minor differences in action limits can significantly affect the proportion of the population classified as needing treatment.

    Conclusions:

    • Discrepancies exist in hyperlipidemia action limits globally.
    • The basis for these limits (observational vs. interventional data) influences population reach.
    • Harmonization or understanding of these differences is crucial for consistent cardiovascular disease prevention strategies.